SARS CoV-2 antibody test; COVID-19 serologic test; COVID-19 - past infection
This blood test shows if you have antibodies against the virus that causes COVID-19. Antibodies are proteins produced by the body in response to harmful substances, such as viruses and bacteria. Antibodies may help protect you from getting infected again (immune).
The COVID-19 antibody test is not used to diagnose a current infection with COVID-19. To test if you are currently infected, you will need a SARS-CoV-2 (or COVID-19) virus test.
A blood sample is needed.
The blood sample will be sent to a laboratory for testing. The test can detect one or more types of antibodies to SARS-CoV-2, the virus that causes COVID-19.
No special preparation is needed.
When the needle is inserted to draw blood, some people feel moderate pain. Others feel only a prick or stinging. Afterward, there may be some throbbing or a slight bruise. This soon goes away.
The COVID-19 antibody test is used for the following:
The test is considered normal when it is negative. If you test negative, you likely have not had COVID-19 in the past.
However, there are other reasons that may explain a negative test result.
The test is considered abnormal when it is positive. This means you have antibodies to the virus that causes COVID-19. A positive test suggests:
You may or may not have had symptoms at the time of the infection.
A positive result does not mean that you are immune to COVID-19. It is not certain if having these antibodies means that you are protected from future infections, or for how long the protection might last. Talk with your provider about what your test results mean.
If you tested positive and you have symptoms of COVID-19, you may need a diagnostic test to confirm an active infection with SARS-CoV-2. You should stay at home and take steps to protect others from getting COVID-19.
Centers for Disease Control and Prevention website. Overview of testing for SARS-CoV-2. www.cdc.gov/covid/hcp/clinical-care/overview-testing-sars-cov-2.html. Updated August 29, 2024. Accessed September 17, 2024.
Del Rio C, Gandhi M, Cohen MS. COVID-19: epidemiology, clinical manifestations, diagnosis, community prevention, and prognosis. In: Goldman L, Cooney K, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 336.
BACK TO TOPReview Date: 2/22/2023
Reviewed By: Frank D. Brodkey, MD, FCCM, Associate Professor, Section of Pulmonary and Critical Care Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team. Editorial update 09/17/2024.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.